Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Breathgreen Healthcare is a medical technology company focused on the development of non-invasive diagnostic solutions through exhaled breath analysis. Utilizing advanced sensor technology and artificial intelligence, the company identifies volatile organic compounds (VOCs) that act as metabolic biomarkers for respiratory and systemic diseases. Their product portfolio is primarily designed for the early detection and management of lung cancer, chronic obstructive pulmonary disease (COPD), and asthma. Breathgreen's technology offers a rapid, cost-effective, and patient-friendly alternative to traditional diagnostic methods. The company aims to integrate breathomics into routine clinical practice to improve screening efficiency and patient monitoring.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Breathgreen Healthcare.